Annual Accounts Payable
$13.65 M
+$3.43 M+33.50%
December 31, 2023
Summary
- As of February 7, 2025, BTAI annual accounts payable is $13.65 million, with the most recent change of +$3.43 million (+33.50%) on December 31, 2023.
- During the last 3 years, BTAI annual accounts payable has risen by +$9.68 million (+243.15%).
- BTAI annual accounts payable is now at all-time high.
Performance
BTAI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$14.89 M
+$1.63 M+12.32%
September 30, 2024
Summary
- As of February 7, 2025, BTAI quarterly accounts payable is $14.89 million, with the most recent change of +$1.63 million (+12.32%) on September 30, 2024.
- Over the past year, BTAI quarterly accounts payable has increased by +$1.24 million (+9.04%).
- BTAI quarterly accounts payable is now -13.54% below its all-time high of $17.22 million, reached on March 31, 2024.
Performance
BTAI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BTAI Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.5% | +9.0% |
| 3 y3 years | +243.2% | +332.9% |
| 5 y5 years | +751.3% | +251.3% |
BTAI Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +191.9% | -13.5% | +218.3% |
| 5 y | 5-year | at high | +243.2% | -13.5% | +496.3% |
| alltime | all time | at high | +4793.9% | -13.5% | +3253.4% |
BioXcel Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.89 M(+12.3%) |
| Jun 2024 | - | $13.26 M(-23.0%) |
| Mar 2024 | - | $17.22 M(+26.1%) |
| Dec 2023 | $13.65 M(+33.5%) | $13.65 M(+28.0%) |
| Sep 2023 | - | $10.67 M(-4.8%) |
| Jun 2023 | - | $11.20 M(+44.7%) |
| Mar 2023 | - | $7.74 M(-24.3%) |
| Dec 2022 | $10.23 M(+118.6%) | $10.23 M(+74.2%) |
| Sep 2022 | - | $5.87 M(-2.5%) |
| Jun 2022 | - | $6.02 M(+18.9%) |
| Mar 2022 | - | $5.07 M(+8.3%) |
| Dec 2021 | $4.68 M | $4.68 M(+36.0%) |
| Sep 2021 | - | $3.44 M(+37.7%) |
| Jun 2021 | - | $2.50 M(-53.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $5.31 M(+33.5%) |
| Dec 2020 | $3.98 M(-19.7%) | $3.98 M(-53.5%) |
| Sep 2020 | - | $8.56 M(-18.0%) |
| Jun 2020 | - | $10.43 M(+55.0%) |
| Mar 2020 | - | $6.73 M(+35.9%) |
| Dec 2019 | $4.95 M(+208.8%) | $4.95 M(+16.9%) |
| Sep 2019 | - | $4.24 M(+6.5%) |
| Jun 2019 | - | $3.98 M(+87.0%) |
| Mar 2019 | - | $2.13 M(+32.7%) |
| Dec 2018 | $1.60 M(+261.3%) | $1.60 M(+32.2%) |
| Sep 2018 | - | $1.21 M(+36.4%) |
| Jun 2018 | - | $889.00 K(-77.4%) |
| Mar 2018 | - | $3.94 M(+786.3%) |
| Dec 2017 | $444.00 K(+59.1%) | $444.00 K |
| Dec 2016 | $279.00 K | - |
FAQ
- What is BioXcel Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual accounts payable year-on-year change?
- What is BioXcel Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly accounts payable year-on-year change?
What is BioXcel Therapeutics annual accounts payable?
The current annual accounts payable of BTAI is $13.65 M
What is the all time high annual accounts payable for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual accounts payable is $13.65 M
What is BioXcel Therapeutics annual accounts payable year-on-year change?
Over the past year, BTAI annual accounts payable has changed by +$3.43 M (+33.50%)
What is BioXcel Therapeutics quarterly accounts payable?
The current quarterly accounts payable of BTAI is $14.89 M
What is the all time high quarterly accounts payable for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly accounts payable is $17.22 M
What is BioXcel Therapeutics quarterly accounts payable year-on-year change?
Over the past year, BTAI quarterly accounts payable has changed by +$1.24 M (+9.04%)